Disclosure Of Entity's Operating Segments [Text Block]

Alligator Bioscience - Filing #690835

Concept	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31
Disclosure of entity's operating segments [text block]	—	Information om geografiska marknader, koncernen	—	—	—	—	—	—
Disclosure of operating segments [text block]	—	—	—	—	—	—	—	—
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Depreciation and amortisation expense	—	11 767 SEK	—	—	—	—	11 144 SEK	—
Tax expense (income)	—	- SEK	—	—	—	—	- SEK	—
Profit (loss) before tax	—	193 403 SEK	—	—	—	—	141 736 SEK	—
Profit (loss)	—	193 403 SEK	193 403 SEK	—	- SEK	- SEK	141 736 SEK	141 736 SEK
Assets	169 584 SEK	—	—	333 200 SEK	—	—	—	—
Cash flows from (used in) operating activities	—	172 607 SEK	—	—	—	—	127 033 SEK	—
Cash flows from (used in) investing activities	—	440,000 SEK	—	—	—	—	45,000 SEK	—
Cash flows from (used in) financing activities	—	7 827 SEK	—	—	—	—	301 795 SEK	—